Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

513 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Erratum dans la « No 396 - Surveillance du bien-être fœtal : Directive clinique de consensus des soins intrapartum » [Journal of Obstetrics and Gynaecology Canada 42 (2020) 349-384.E10].
Dore S, Ehman W, Azzam H, Basso M, Bow M, Morin F, Mundle W, Rivard L, Sawchuck D, Wilson K, Young D. Dore S, et al. Among authors: morin f. J Obstet Gynaecol Can. 2021 Sep;43(9):1119. doi: 10.1016/j.jogc.2021.07.009. J Obstet Gynaecol Can. 2021. PMID: 34481582 No abstract available.
Turncoat antibodies unmasked in a model of autoimmune demyelination: from biology to therapy.
Taghipour-Mirakmahaleh R, Morin F, Zhang Y, Bourhoven L, Béland LC, Zhou Q, Jaworski J, Park A, Dominguez JM, Corbeil J, Flanagan EP, Marignier R, Larochelle C, Kerfoot S, Vallières L. Taghipour-Mirakmahaleh R, et al. Among authors: morin f. bioRxiv [Preprint]. 2024 Dec 6:2024.12.03.623846. doi: 10.1101/2024.12.03.623846. bioRxiv. 2024. PMID: 39677612 Free PMC article. Preprint.
Real-world efficacy of the dabrafenib-trametinib (D-T) combination in BRAF V600E-mutated metastatic non-small cell lung cancer (NSCLC): Results from the IFCT-2004 BLaDE cohort.
Swalduz A, Beau-Faller M, Planchard D, Mazieres J, Bayle-Bleuez S, Debieuvre D, Fallet V, Geier M, Cortot A, Couraud S, Daniel C, Domblides C, Pichon E, Fabre E, Larivé S, Lerolle U, Tomasini P, Wislez M, Missy P, Morin F, Westeel V, Auliac JB. Swalduz A, et al. Among authors: morin f. Lung Cancer. 2024 Nov 26;199:108038. doi: 10.1016/j.lungcan.2024.108038. Online ahead of print. Lung Cancer. 2024. PMID: 39616778
Lurbinectedin in extensive-stage small-cell lung cancer: a brief report of the IFCT-2105 LURBICLIN study.
Girard N, Guisier F, Swalduz A, Van Hulst S, Pichon E, Lavaud P, Greillier L, Tiotiu A, Madroszyk A, Bylicki O, Canellas A, Belmont L, Zysman M, Hauss PA, Godbert B, Audigier-Valette C, Lebreton C, Morin F, Westeel V. Girard N, et al. Among authors: morin f. ESMO Open. 2024 Dec;9(12):103968. doi: 10.1016/j.esmoop.2024.103968. Epub 2024 Nov 27. ESMO Open. 2024. PMID: 39608302 Free PMC article.
The urotensin II receptor triggers an early meningeal response and a delayed macrophage-dependent vasospasm after subarachnoid hemorrhage in male mice.
Pedard M, Prevost L, Carpena C, Holleran B, Desrues L, Dubois M, Nicola C, Gruel R, Godefroy D, Deffieux T, Tanter M, Ali C, Leduc R, Prézeau L, Gandolfo P, Morin F, Wurtz O, Bonnard T, Vivien D, Castel H. Pedard M, et al. Among authors: morin f. Nat Commun. 2024 Sep 29;15(1):8430. doi: 10.1038/s41467-024-52654-2. Nat Commun. 2024. PMID: 39341842 Free PMC article.
Capmatinib efficacy for METex14 non-small cell lung cancer patients: Results of the IFCT-2104 CAPMATU study.
Ferreira M, Swalduz A, Greillier L, du Rusquec P, Curcio H, Raimbourg J, Toffart AC, Gounant V, Couraud S, De Chabot G, Friard S, Hureaux J, Jeannin G, Odier L, Ricordel C, Wislez M, Descarpentries C, Herbreteau G, Missy P, Morin F, Westeel V, Cortot AB. Ferreira M, et al. Among authors: morin f. Lung Cancer. 2024 Oct;196:107934. doi: 10.1016/j.lungcan.2024.107934. Epub 2024 Aug 24. Lung Cancer. 2024. PMID: 39277916 Clinical Trial.
Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study.
Fisher BA, Mariette X, Papas A, Grader-Beck T, Bootsma H, Ng WF, van Daele PLA, Finzel S, Noaiseh G, Elgueta S, Hermann J, McCoy SS, Akpek E, Bookman A, Sopala M, Montecchi-Palmer M, Luo WL, Scheurer C, Hueber W; TWINSS study group. Fisher BA, et al. Lancet. 2024 Aug 10;404(10452):540-553. doi: 10.1016/S0140-6736(24)01211-X. Epub 2024 Jul 31. Lancet. 2024. PMID: 39096929 Clinical Trial.
Study design and rationale for IFCT- 2203 TAXIO: A study that aims to evaluate the effectiveness of a first-line chemotherapy regimen without etoposide, combined with durvalumab, for patients with extensive disease small cell lung cancer.
Moro-Sibilot D, Falchero L, Ardin C, Zouak A, Molinier O, Romand P, Leleu O, Amrane K, Berndt C, Langlais A, Morin F, Westeel V. Moro-Sibilot D, et al. Among authors: morin f. Respir Med Res. 2024 Nov;86:101113. doi: 10.1016/j.resmer.2024.101113. Epub 2024 Apr 30. Respir Med Res. 2024. PMID: 38843598 Free article. Clinical Trial.
513 results